statistiche ricercatore

Nome	#
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease	58
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders	41
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics	40
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1	37
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis	30
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis	17
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma	15
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders”	15
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile	14
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer	12
Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders	11
Natural and semisynthetic bile acids as Leukemia Inhibitory Factor (LIF) receptor antagonists	10
Totale	300

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	22	0	0	0	0	0	0	0	4	0	5	6	7
2022/2023	54	7	5	0	6	3	4	6	3	15	0	5	0
2023/2024	93	18	3	10	5	3	0	4	9	2	6	27	6
2024/2025	131	24	22	16	44	25	0	0	0	0	0	0	0
Totale													300